Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma is a research paper published in Frontiers in Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA250069
National Institutes of Health
Grant: 5R21CA232891-02
Clonal Immunoglobulin DNA and Lymphoma Diagnosis
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
National Institutes of Health
Grant: 5R01CA250069-05
Hodgkin Lymphoma in PLWH in South Africa: TB, EBV, and Tumor Molecular Markers
FWCI
2.03
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals